STAT

STAT+: AstraZeneca’s experimental COPD treatment posts strong results in late-stage studies

STAT+: AstraZeneca’s experimental COPD treatment posts strong results in late-stage studiesWorldPing

An experimental COPD drug from AstraZeneca could prove competitive with existing treatments, and have a slice of the market to itself.

This is a short WorldPing brief. The full report was published by STAT.

Read the full report at STAT

More coverage: all health news on WorldPing.

Related news